基于影像组学标记物与容积分析法解码不同疾病特异性生存期肺腺癌肿瘤表型的比较
回顾性纳入431例CT表现为亚实性结节的经病理确诊肺腺癌,提取影像组学特征并用支持向量机区分原位腺癌/微浸润腺癌与浸润性腺癌。影像组学标记物诊断准确率80.5%(Az 0.829,敏感度72.1%,特异度80.9%),显著高于容积分析法69.5%(P=0.049),回归分析中AIC值81.2%优于70.8%。
要点
- CT影像组学标记物区分AIS/MIA与IAC的准确率80.5%,高于容积分析69.5%(P=0.049)。
- 影像组学标记物敏感度72.1%、特异度80.9%、Az值0.829。
- 回归分析中影像组学标记物AIC值81.2%优于容积分析70.8%。
核心结论
- 影像组学肿瘤表型标记物在区分不同疾病特异性生存期的肺腺癌方面,诊断准确率优于传统容积分析法。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并符合HIPAA,纳入431例CT表现为亚实性结节的经病理确诊肺腺癌;采用计算机辅助分割法测量体积和实性体积百分比,从分割的感兴趣容积中提取量化强度、纹理和小波特征的影像组学特征,用Relief方法选择20个最佳特征并输入支持向量机区分AIS/MIA与IAC,通过ROC分析和逻辑回归分析与容积分析法比较。
诊断标准与关键数值
- 影像组学标记物预测AIS/MIA与IAC的ROC分析准确率80.5%(Az值0.829,敏感度72.1%,特异度80.9%);容积分析法准确率69.5%(P=0.049)。回归分析AIC值:影像组学标记物81.2%,容积分析70.8%。
临床应用与阅片要点
- 作者认为影像组学有助于评估肺腺癌内的肿瘤异质性。
- 作者认为影像组学标记物可能有助于更有信心地做出医疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare a multi-feature-based radiomic biomarker with volumetric analysis in discriminating lung adenocarcinomas with different disease-specific survival on computed tomography (CT) scans.
METHODS: This retrospective study obtained institutional review board approval and was Health Insurance Portability and Accountability Act (HIPAA) compliant. Pathologically confirmed lung adenocarcinoma (n = 431) manifested as subsolid nodules on CT were identified. Volume and percentage solid volume were measured by using a computer-assisted segmentation method. Radiomic features quantifying intensity, texture and wavelet were extracted from the segmented volume of interest (VOI). Twenty best features were chosen by using the Relief method and subsequently fed to a support vector machine (SVM) for discriminating adenocarcinoma in situ (AIS)/minimally invasive adenocarcinoma (MIA) from invasive adenocarcinoma (IAC). Performance of the radiomic signatures was compared with volumetric analysis via receiver-operating curve (ROC) analysis and logistic regression analysis.
RESULTS: The accuracy of proposed radiomic signatures for predicting AIS/MIA from IAC achieved 80.5% with ROC analysis (Az value, 0.829; sensitivity, 72.1%; specificity, 80.9%), which showed significantly higher accuracy than volumetric analysis (69.5%, P = 0.049). Regression analysis showed that radiomic signatures had superior prognostic performance to volumetric analysis, with AIC values of 81.2% versus 70.8%, respectively.
CONCLUSIONS: The radiomic tumour-phenotypes biomarker exhibited better diagnostic accuracy than traditional volumetric analysis in discriminating lung adenocarcinoma with different disease-specific survival.
KEY POINTS: • Radiomic biomarker on CT was designed to identify phenotypes of lung adenocarcinoma • Built up radiomic signature for lung adenocarcinoma manifested as subsolid nodules • Retrospective study showed radiomic signature had greater diagnostic accuracy than volumetric analysis • Radiomics help to evaluate intratumour heterogeneity within lung adenocarcinoma • Medical decision can be given with more confidence.
引用
- Yuan M, Zhang YD, Pu XH, et al. Comparison of a radiomic biomarker with volumetric analysis for decoding tumour phenotypes of lung adenocarcinoma with different disease-specific survival. Eur Radiol. 2017. PMID: 28523350. doi:10.1007/s00330-017-4855-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。